Entyvio 300 MG vials
Ended Awarded
- Contract number
- SPE2DB25FH5EE
- Awardee
-
DMS Pharmaceutical Group Inc. UEI PX72BSBQTKJ3
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $49,449
Award facts
- Contract value 100% obligated
- $49,449.30 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Park Ridge, IL 60068, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency awarded a $49,449.30 firm fixed-price delivery order to DMS Pharmaceutical Group Inc. on September 3, 2025, for the supply of Entyvio 300 mg vials, with an ultimate completion date of September 24, 2025. This delivery order was issued without a set-aside designation and represents a continuation of the agency's pharmaceutical supply operations. DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, serves as the prime contractor, with no subcontractors identified in this award.
This delivery order is issued under DMS Pharmaceutical Group's larger Indefinite Delivery Contract with the Defense Logistics Agency valued at $499,999,999 and valid through November 2026. Under this IDC, the DLA issues firm fixed-price delivery orders for a comprehensive range of pharmaceutical items supporting medical supply needs of military health facilities worldwide. Entyvio, a biologic medication used for inflammatory bowel disease treatment, reflects the company's demonstrated capability to supply specialty pharmaceutical products to Department of Defense healthcare sites. As a consistent performer in the federal pharmaceutical supply chain since 2001, DMS Pharmaceutical Group has established itself as a critical supplier for the military health system's prescription drug and biologics distribution requirements.
Quick answers
Who was awarded contract SPE2DB25FH5EE?
SPE2DB25FH5EE was awarded to DMS Pharmaceutical Group Inc. by Defense Logistics Agency (Department of Defense) on September 3, 2025.
How much is contract SPE2DB25FH5EE worth?
The government has obligated $49,449 on SPE2DB25FH5EE.
Is contract SPE2DB25FH5EE an order under another contract?
Yes. SPE2DB25FH5EE is a delivery order under SPE2DB22D9207, an indefinite delivery contract.
Was contract SPE2DB25FH5EE competed?
The extent of competition for SPE2DB25FH5EE was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award